Role of lipoprotein-associated phospholipase A2 in atherosclerosis

被引：0
|
作者：
Shahar Lavi
Joerg Herrmann
Ronit Lavi
Joseph P. McConnell
Lilach O. Lerman
Amir Lerman
机构：
[1] Mayo Clinic,Division of Cardiovascular Diseases
来源：
Current Atherosclerosis Reports | 2008年 / 10卷
关键词：
Acute Coronary Syndrome; Stable Coronary Artery Disease; Arterioscler Thromb Vasc Biol; Coronary Endothelial Dysfunction; Stable Coronary Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a biomarker that can be used to assess the risk for cardiovascular disease and events. In addition to being a useful marker of a risk factor, several studies suggest that Lp-PLA2 has a pathophysiologic role in the atherosclerotic disease process. In this article, we review this aspect and its therapeutic implications.
引用
收藏
相关论文
共 50 条
  • [41] Lipoprotein-associated phospholipase A2 is associated with risk of dementia
    van Oijen, M
    van der Meer, IM
    Hofman, A
    Witteman, JCM
    Koudstaal, PJ
    Breteler, MMB
    ANNALS OF NEUROLOGY, 2006, 59 (01) : 139 - 144
  • [42] Lipoprotein and Lipoprotein-associated Phospholipase A2 as Atherosclerosis Risk Factors (oxLDL) in Men with Central Obesity
    Sari, Nelly
    Wijaya, Andi
    Patellongi, Ilhamjaya
    INDONESIAN BIOMEDICAL JOURNAL, 2011, 3 (01): : 51 - 56
  • [43] Role of lipoprotein-associated phospholipase A2 in predicting risk of cardiovascular disease
    Myerson, Merle
    MAYO CLINIC PROCEEDINGS, 2007, 82 (07) : 888 - 888
  • [44] Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses
    Shi, Yi
    Zhang, Ping
    Zhang, LiFeng
    Osman, Hashim
    Mohler, Emile R., III
    Macphee, Colin
    Zalewski, Andrew
    Postle, Anthony
    Wilensky, Robert L.
    ATHEROSCLEROSIS, 2007, 191 (01) : 54 - 62
  • [45] Lipoprotein-associated phospholipase A2 levels in the coronary circulation are associated with early coronary atherosclerosis in humans
    Lavi, Shahar
    Rihal, Charanjit S.
    Prasad, Abhiram
    Mathew, Verghese
    Barsness, Gregory W.
    McConnell, Joseph P.
    Lerman, Lilach O.
    Lerman, Amir
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 214M - 214M
  • [46] Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography
    Dohi, Tomotaka
    Miyauchi, Katsumi
    Ohkawa, Ryunosuke
    Nakamura, Kazuhiro
    Thuboi, Shuta
    Ogita, Manabu
    Miyazaki, Tadashi
    Nishino, Akihisa
    Yokoyama, Ken
    Kurata, Takeshi
    Yatomi, Yutaka
    Daida, Hiroyuki
    ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 : 527 - 533
  • [47] Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis
    Kolodgie, Frank D.
    Burke, Allen P.
    Skorija, Kristi S.
    Ladich, Elena
    Kutys, Robert
    Makuria, Addisalem Taye
    Virmani, Renu
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (11) : 2523 - 2529
  • [48] Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis
    Zhang, Juan
    Xu, Dong-Ling
    Liu, Xiao-Bo
    Bi, Shao-jie
    Zhao, Tong
    Sui, Shu-Jian
    Ji, Xiao-Ping
    Lu, Qing-Hua
    YONSEI MEDICAL JOURNAL, 2016, 57 (02) : 321 - 327
  • [49] Research Advance of Chinese Medicine in Treating Atherosclerosis: Focus on Lipoprotein-Associated Phospholipase A2
    Wang, Lu-ming
    Zhang, Wen-lan
    Lyu, Nuan
    Suo, Yan-rong
    Yang, Lin
    Yu, Bin
    Jiang, Xi-juan
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2024, 30 (03) : 277 - 288
  • [50] Regulation of lipoprotein-associated phospholipase A2 silencing on myocardial fibrosis in mice with coronary atherosclerosis
    Pan, Guozhong
    Kou, Lanjun
    Wu, Yang
    Hu, Yuanji
    Lin, Xiaoshuo
    Guo, Jinrui
    Ren, Xiaoxia
    Zhang, Yan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 514 (02) : 450 - 455
12345